If you want to prepare yourself for the next 10 years of your career, then I invite you to join me at this year's 2018 ISPE Biopharmaceutical Manufacturing Conference, 10 -12 December, Huntington Beach, California, a conference focused on a fascinating and challenging future that is just around the corner. Our theme says it all…..
We’ve brought together regulators and practitioners who are meeting the challenge of industrializing personalized medicine, expanding into Oligonucleotides and ADC’s, and charting the path to Continuous Biomanufacturing. Register now to learn and network with these industry and regulatory leaders who are on the forefront of this transformation.
As novel therapies emerge from the clinic and provide dramatic improvement in disease treatment, the biopharmaceutical professional of today must be prepared to design, build, operate, and support the new and different facilities and processes required to meet demand. To twist a phrase, “This won’t be your parents biopharm plant”
If you’ve started on this journey, then come share and compare experiences with our talented speaker panels during Q&A and networking sessions, take new information away, and help your peers learn from your experiences.
Highlights include:
I hope you will join me in California this December as we explore, strategize, develop tools, and determine how to navigate the evolving technical and regulatory complexities of biopharm’s exciting future. Register now to learn and network with industry, academic researchers and regulatory leaders who are on the forefront of this transformation.
Best regards,
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...